the aid library

Convention on Biological Diversity (2020) C2

Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the further implementation of the Convention. GBO-5 pro... more

Infección por SARS-CoV-2 y tuberculosis pulmonar: análisis de la situación en el Perú

Aguilar-León, P et al. Cadernos de Saúde Pública (2020) CC

SARS-CoV-2 infection and pulmonary tuberculosis: analysis of the situation in Peru

External Link

WHO Global Atlas of Traditional, Complementary and Alternative Medicines. Text and map volume

Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, Burford, Gemma, Shein, Kin. et al. (‎2005)‎. WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japa World Health Organization WHO (2005) C_WHO

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download

View PDF

Water, Sanitation and Hygiene: The foundation for building resilience in climate‑vulnerable communities

Omasete J., Forster J., Geere J., et al. Water Aid (2022) CC

This report, which involved input from across WaterAid, in particular from the Programme Support Unit (PSU) of WaterAid UK, includes case studies from a variety of countries, including Bangladesh, Burkina Faso, Eswatini, Ethiopia, Ghana, India and Nepal, each demonstrating what must be done now to i... more

Download

View PDF

Plan Nacional de repuesta a la resistencia a los antimicrobianos

Dirección de Medicamentos y Tecnologías en Salud, Colombia (2018) C1

Plan Estratégico

Download

View PDF

Criterios de diagnóstico y tratamiento de la tuberculosis infantil

Gonzales N., et al. (2022) CC

El agente etiológico de la tuberculosis es el Mycobacterium tuberculosis o bacilo de Koch. Se trata de un bacilo aerobio estricto, ácido-alcohol resistente, sin movilidad, de crecimiento lento y que se inactiva con rayos ultravioleta y temperaturas mayores de 60°C.

Download

View PDF

COVID-19: Implications for People with Chagas Disease

Zaidel, E.J.; et al. (2020) CC

Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.

Informe Impacto de La Pandemia COVID-19 en las Enfermedades no Transmisibles en Chile 2022

Ministerio de Salud, Gobierno de Chile (2022) C1

Informe

External Link

Desarrollo de guías de práctica clínica basadas en evidencia en Perú desde el sector público

García-Mostajo, J.A.; Alva-Díaz, C.; Suárez, V.; et al. (2017) CC

Acta Med Peru. 2017;34(3):203-7 En el Perú, la elaboración de guías de práctica clínica tiene exigencia normativa desde el año 2005; sin embargo, su desarrollo ha ténido poco énfasis en la calidad metodológica de las mismas, prefiriendo el tipo narrativo. Desde hace varios años se realiz... more

External Link

Peru − Progress in health and sciences in 200 years of independence

Carrillo-Larco; R.M.; Guzman-Vilca, W. C.; Leon-Velarde, F.; et al. The Lancet Regional Health - Americas (2021) CC

Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and... more

Guía de medicina tradicional para abordaje de la COVID-19

Ministerio de Salud, Bolivia (2021) C1

Serie: Documentos Técnico Normativiso 495

Guía de Práctica Clínica Enfermedad Pulmonar Obstructiva Crónica

Ministerio de Salud, Gobierno de Chile (2019) C1

Resumen Ejecutivo

Download

View PDF

Urban Ecosystem-based Adaptation: Regreening Cities to Takle Climate Change

UN Enivronemnt Programme UNEP (2022) CC

Briefing Note 8. Ecosystem-based adaptation (EbA) is a strategy for adapting to the adverse impacts of climate change by harnessing nature and the services it can provide. This strategy is crucial for cities and peri-urban areas, threatened by a multitude of climate hazards and home to more than ha... more

Download

View PDF

L’adaptation fondée sur les écosystèmes dans les zones urbaines reverdir les villes pour lutter contre les changements climatiques

UN Enivronemnt Programme UNEP UNEP (2022) CC

Note de synthese 8

Download

View PDF

Adaptación basada en los ecosistemas urbanos reverdecimiento de las ciudades para luchar contra el cambio climático

UN Enivronemnt Programme UNEP (2022) CC

Nota inormative 8

Global Vaccine Market Report 2022

World Health Organization WHO (2022) C_WHO

The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ... more

Control measures for Shiga toxin-producing Escherichia coli (‎STEC)‎ associated with meat and dairy products: meeting report

World Health Organisation (WHO) (2022) C_WHO

Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the... more

Download

View PDF

Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia

Marchiol, A; Forsyth, C.; Bernal, O.; et al. Pan American Health Organization PAHO (2017) C_WHO

Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153 Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co... more

External Link

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases

Brindha, J.; Balamurali, M.; Kaushik, C. Frontiers in Chemistry (2021) C1

Front Chem. 2021; 9: 622286. Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286